New Paper Published: DMT Usage and Education

Blogs, Research

We have recently had a paper published in Multiple Sclerosis Journal which looks at DMTs (disease modifying therapies) and education, using data from our participants on the Register.

We know that disease modifying therapies (DMTs) are available to some people with MS and can help slow down MS progression and reduce relapses. This study looked at whether education levels have an impact on who takes DMTs.

The study used data from over 6,000 adults diagnosed with relapsing-remitting MS between 2008 and 2021 in the UK. We compared people who went to university versus those with lower education levels. We then looked at whether education level affected who started taking DMTs or got treated with more effective DMTs.

What We Found

The results showed that those who went to university were more likely to use DMTs than those who did not, even though the UK has public healthcare intended to provide equal access. We found that 62% of university educated people used DMTs, compared to only 53% of those with lower education.

People who went to university were also more likely to take moderate or high efficacy DMTs.

Going to university also predicted starting medications more quickly after an MS diagnosis.

In summary, even with public healthcare, differences existed – those with higher education in the UK more often used medications to manage their MS. This indicates an important area for further study and changes in policy to make sure treatment access is equal.